Altered intestinal microbiota in patients with chronic pancreatitis: Implications in diabetes and metabolic abnormalities

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Jandhyala, Sai Manasa ^a   Madhulika, A ^b   Deepika, G ^b   Rao, G Venkat ^b   Reddy, D Nageshwar ^b   Subramanyam, Chivukula ^a   Sasikala, Mitnala ^a   Talukdar, Rupjyoti ^a,b  

^a Asian Healthcare Foundation   (India)

^b ASIAN INSTITUTE OF GASTROENTEROLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BIODIVERSITY; CASE CONTROL STUDY; CHRONIC PANCREATITIS; COMPLICATION; DISEASE EXACERBATION; DYSBIOSIS; ENERGY METABOLISM; FEMALE; HUMAN; INTESTINE FLORA; MALE; METABOLIC DISORDER; METAGENOME; METAGENOMICS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROCEDURES;

ADULT; BIODIVERSITY; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; DYSBIOSIS; ENERGY METABOLISM; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; METABOLIC DISEASES; METAGENOME; METAGENOMICS; MIDDLE AGED; PANCREATITIS, CHRONIC;

EID: 85014672496     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep43640     Document Type: Article

References (36)

1. Majumder, S. & Chari, S. T. Chronic pancreatitis. Lancet. 29, 1957-1966 (2016).
2. Rickels. M. R. et al. Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: Recommendations from PancreasFest 2012. Pancreatology. 13, 336-342 (2013).
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 35, S64-S71 (2012).
4. Zhou, X. & You, S. Rosiglitazone inhibits hepatic insulin resistance induced by chronic pancreatitis and IKK-β /NF-κ B expression in liver. Pancreas. 43, 1291-1298 (2014).
5. Farrell, J. J. et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 61, 582-588 (2012).
6. Capurso, G., Signoretti, M., Archibugi, L., Stigliano, S. & Fave, G. D. Systematic review and meta-Analysis: Small intestinal bacterial overgrowth in chronic. Pancreatitis. United European Gastroenterology J. 4, 697-705 (2016).
7. David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 505, 559-563 (2014).
8. De Fillipo, C. et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 107, 14691-14696 (2010).
9. Dethlefsen, L., McFall-Ngai, M. & Relman, D. A. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 449, 811-818 (2007)
10. Goodrich, J. K. et al. Human genetic shape the gut microbiome. Cell. 159, 789-799 (2014).
11. Walker, A. W. et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISMEJ. 5, 220-230 (2011).
12. Louis, P. & Flint, H. J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett. 94, 1-8 (2009).
13. Rossi, O. et al. Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses. Sci. Rep. 6, 18507 (2015).
14. Wrzosek, L. et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 11, 61 (2013).
15. Martín, R. et al. Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiology. 15, 67 (2015).
16. Ze, X. Unique organization of extracellular amylases into amylosomes in the resistant starch-utilizing human colonic firmicutes bacterium ruminococcus bromii. MBio. 6, e01058-15 (2015).
17. Ze, X., Duncan, S. H., Louis, P. & Flint, H. J. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J. 6, 1535-1543 (2012).
18. Amyot, J., Semache, M., Ferdaoussi, M., Fontis, G. & Poitout, V. Lipopolysaccharides impair insulin gene expression in isolated islets of Langerhans via Toll-Like Receptor-4 and NF-κB signalling. PLoS One. 7, e36200 (2012).
19. Pavan, P. K. et al. Interferon γ and glycemic status in diabetes associated with chronic pancreatitis. Pancreatology. 12, 65-70 (2012).
20. Talukdar, R. et al. T-helper cell-mediated islet inflammation contributes to β-cell dysfunction in chronic pancreatitis. Pancreas. 45, 434-442 (2016).
21. Tilg, H. & Moschen, A. R. Microbiota and diabetes: An evolving relationship. Gut. 63, 1513-21 (2014).
22. Jandhyala, S. M. et al. Role of the normal gut microbiota. World J Gastroenterol. 21, 8787-8803 (2015).
23. Garg, P. K. Chronic pancreatitis in India and Asia. Curr Gastroenterol Rep. 14, 118-124 (2012).
24. Balakrishnan, V. et al. Chronic Pancreatitis. A Prospective Nationwide Study of 1,086 Subjects from India. JOP. 9, 593-600 (2008).
25. Talukdar, R., Rao, G. V. & Reddy, D. N. Risk factors for development of secondary diabetes in chronic pancreatitis and impact of ductal decompression. Pancreatology. 13, S27 (2013).
26. Talukdar, R. & Reddy, D. N. Pain in chronic pancreatitis: managing beyond the pancreatic duct. World J Gastroenterol. 14, 6319-6328 (2013).
27. Talukdar, R. & Reddy, D. N. Is there a single therapeutic target for chronic pancreatitis pain? Gastroenterology. 144, e18 (2013).
28. American Diabetes Association. Executive summary: Standards of medical care in diabetes-2014. Diabetes Care. 37, S5-S13 (2014).
29. Detsky, A. S. et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr. 11, 8-13 (1987).
30. Hoffmeister, A. et al. English language version of the S3-consensus guidelines on chronic pancreatitis: Definition, aetiology, diagnostic examinations, medical, endoscopic and surgical management of chronic pancreatitis. Z Gastroenterol. 53, 1447-1495 (2015).
31. Lai, L. C. Global standardization of HbA1c. Malays J Pathol. 30, 67-71 (2008).
32. Webster, C. J. Principles of a quantitative assay for bacterial endotoxins in blood that uses Limulus lysate and a chromogenic substrate. J Clin Microbiol. 12, 644-650 (1980).
33. Keim, V., Teich, N. & Moessner, J. Clinical value of a new fecal elastase test for detection of chronic pancreatitis. Clin Lab. 49, 209-215 (2003).
34. Meyer, F. et al. The metagenomics RAST server-A public resource for the automatic phylogenetic and functional analysis of metagenomes. BMC Bioinformatics. 9, 386 (2008).
35. Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation.Nucleic Acids Res. 44, D457-D462 (2016).
36. Hill, M. O. Diversity and evenness: A unifying notation and its consequences. Ecology. 54, 427-432 (1973).